Locations:
Search IconSearch
January 10, 2017/Urology & Nephrology/Urology

Robotic Ureterocalicostomy for Management of Severe Ureteropelvic Junction Obstruction

Rarely used option saves patient’s renal function

650×450-krishnan-gettyimages-101738591

By Jayram Krishnan, DO, MBA

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Case vignette

Krishnan_Jay

Jayram Krishnan, DO, MBA

A 38-year-old male presented with intermittent right flank pain. Radiographic examination showed right-sided hydronephrosis secondary to a ureteropelvic junction obstruction (UPJO). A 2-mm stone was also noted in his right renal pelvis. A MAG-3 renal scan demonstrated a split differential of 56 percent on the left kidney and 44 percent on the right kidney. Because the patient’s pain was manageable, he opted for observation with periodic radiographic imaging.

One year later, the patient returned with a CT scan showing the stone in his right renal pelvis had enlarged to 14 mm, and his split differential function on the right kidney had dropped to 34 percent. He had worsening hydronephrosis on imaging, as well as a high-grade UPJO (Figure 1). At this point, we decided to perform surgical intervention in order to preserve his remaining kidney function.

inset-krishnan-figure-1

Figure 1

We reviewed the patient’s treatment options, and he chose to undergo robotic right-sided pyeloplasty with pyelolithotomy. During surgery, we discovered his UPJO was more significant than had been indicated on preoperative imaging. Issues included a long, atretic proximal ureteral segment with intrinsic smooth muscle disease. Nevertheless, we completed the robotic pyeloplasty and left a ureteral stent in place postoperatively.

Four weeks later, cystoscopy with right retrograde pyelography demonstrated small wisps of contrast extravasing from the anastomotic repair. We decided to leave the stent in place for another month, at which time the anastomosis would be reevaluated.

Advertisement

Four weeks later, a CT urogram demonstrated severe persistent right-sided hydronephrosis. At this point, there were three options to preserve renal function:

  • Exchanging stents every three to six months
  • Repeating the pyeloplasty
  • Performing robotic ureterocalicostomy

Because our patient expressed a desire for definitive repair of his right kidney, we proceeded with robotic ureterocalicostomy.

Robotic ureterocalicostomy for preservation of renal function

Robotic ureterocalicostomy is a rarely performed treatment reserved for patients who have failed all other treatment modalities for UPJO. Although the procedure was developed in 1947 and mimics the principals of traditional open surgery, its adoption as a minimally invasive approach has been slow, largely due to technical challenges.

In ureterocalicostomy, the proximal ureter is directly connected to the lower pole of the kidney. In this patient, we performed the procedure laparoscopically with robotic assistance. First, we identified the proximal ureteral tissue and brought the ureter towards the lower pole of the kidney. The lower pole was then incised to make a calyx. A tension-free anastomosis was performed. A ureteral stent was placed and removed four weeks later in the office through cystoscopy.

One year later, our patient has no flank pain and enjoys preserved right-sided renal function.

The take-home message

Ureterocalicostomy should be considered in patients who have failed previous treatments for UPJO, as the procedure offers long-term benefit in the preservation of existing renal function.

Robotic ureterocalicostomy offers the same outcomes as traditional open surgery with less pain, less blood loss and a faster return to normal activities.

Advertisement

Dr. Krishnan is a urologist with a specialty interest in robotic surgery at Cleveland Clinic Urology, Las Vegas.

Advertisement

Related Articles

CT scan of female patient bladder cancer
November 26, 2024/Urology & Nephrology/Urology
Use of Interim Imaging To Preserve Eligibility for Vaginal-Sparing Cystectomy

Retrospective study evaluates clinical upstaging during neoadjuvant treatment

Microscopic view of bladder cancer with variant histology
November 19, 2024/Urology & Nephrology/Urology
Nonmuscle Invasive Bladder Cancer With Variant Histology: When To Consider a Bladder-Sparing Approach

Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy

Single-port robot docked in the operating room
November 12, 2024/Urology & Nephrology/Urology
Single-Port Pyeloplasty in a Pediatric Patient: A Novel Surgical Technique

Revolutionizing pediatric urology with a new, less invasive approach

Physician smiles at patient in a preoperative setting
September 12, 2024/Urology & Nephrology/Urology
Improving the Bladder Cancer Survivorship Experience for Women

What updated techniques, counseling and a changing workforce could mean

Surgeons in the operating room with the single-port robot
Novel Single-Port Robotic Urology Surgery Surpasses 1,000 Cases

Applications, outcomes and untapped potential

Photo of Dr. Bajic
Counseling Your Patients on SGLT-2 Inhibitors and Adverse Urologic Outcomes

Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes

Illustration of red blood cells in motion
Review Underscores Impact of Red Blood Cell Disorders on Male Reproduction

Early, individualized diagnosis and comprehensive management key to preserving fertility

UTI bacteria and artificial intelligence
AI Algorithms Accurately Predict Antibiotic Resistance in UTI

Up to 3 days faster than waiting for urine culture results

Ad